Titan Biotech's Asset Turnover Ratio tells a powerful story: from 1.18x in FY2015 to a peak of 1.42x during COVID demand to 0.94x during the current capex phase. A deep-dive case study.
📅 Published April 08, 2026 (Wednesday) Why Most Indian Retail Investors Ignore the One Ratio That Could Save Them from Catastrophic Losses The Indian stock market […]
In the Indian stock market, there is one silent killer that has destroyed more retail investor wealth than any market crash, any earnings miss, or any […]
In the world of fundamental analysis, few things excite a value investor more than watching a company quietly build a growing pile of cash and investments […]